IE882030L - Dopamine-beta-hydroxylase inhibitors - Google Patents

Dopamine-beta-hydroxylase inhibitors

Info

Publication number
IE882030L
IE882030L IE203088A IE203088A IE882030L IE 882030 L IE882030 L IE 882030L IE 203088 A IE203088 A IE 203088A IE 203088 A IE203088 A IE 203088A IE 882030 L IE882030 L IE 882030L
Authority
IE
Ireland
Prior art keywords
dopamine
beta
hydroxylase inhibitors
hydroxylase
inhibitors
Prior art date
Application number
IE203088A
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Priority to IE203088A priority Critical patent/IE882030L/en
Publication of IE882030L publication Critical patent/IE882030L/en

Links

IE203088A 1988-07-04 1988-07-04 Dopamine-beta-hydroxylase inhibitors IE882030L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE203088A IE882030L (en) 1988-07-04 1988-07-04 Dopamine-beta-hydroxylase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IE203088A IE882030L (en) 1988-07-04 1988-07-04 Dopamine-beta-hydroxylase inhibitors

Publications (1)

Publication Number Publication Date
IE882030L true IE882030L (en) 1989-01-09

Family

ID=11032378

Family Applications (1)

Application Number Title Priority Date Filing Date
IE203088A IE882030L (en) 1988-07-04 1988-07-04 Dopamine-beta-hydroxylase inhibitors

Country Status (1)

Country Link
IE (1) IE882030L (en)

Similar Documents

Publication Publication Date Title
ZA884838B (en) Dopamine-beta-hydroxylase inhibitors
ZA883851B (en) Dopamine-beta-hydroxylase inhibitors
ZA865775B (en) Dopamine-beta-hydroxylase inhibitors
HU906389D0 (en) New alpha-glycosidase inhibitors
PT85081A (en) Irreversible dopamine-beta-hydroxylase inhibitors
PT83628A (en) Dopamine-beta-hydroxylase inhibitors
ZA889709B (en) Dopamine-beta-hydroxylase inhibitors
ZA889667B (en) Dopamine-beta-hydroxylase inhibitors
ZA873653B (en) Dopamine-beta-hydroxylase inhibitors
ZA8892B (en) Dopamine-beta-hydroxylase inhibitors
ZA882100B (en) Dopamine-beta-hydroxylase inhibitors
ZA876394B (en) Dopamine-beta-hydroxylase inhibitors
AU4553889A (en) Dopamine-beta-hydroxylase inhibitors
PT83626A (en) Dopamine-beta-hydroxylase inhibitors
AU4553689A (en) Dopamine-beta-hydroxylase inhibitors
PT81973A (en) Dopamine-beta-hydroxylase inhibitors
IE880860L (en) Dopamine-beta-hydroxylase inhibitors
IE882030L (en) Dopamine-beta-hydroxylase inhibitors
ZA882275B (en) Dopamine-beta-hydroxylase inhibitors
IE883872L (en) Dopamine-beta-hydroxylase inhibitors.
IE893832L (en) DOPAMINE-ß-HYDROXYLASE INHIBITORS
ZW4285A1 (en) Dopamine-beta-hydroxylase inhibitors
ZA842963B (en) Dopamine-beta-hydroxylase inhibitors
ZA842962B (en) Dopamine-beta-hydroxylase inhibitors
IE883871L (en) Dobamine-beta-hydroxylase inhibitors.